United States Cetuximab Market Report 2016

December 2016 | 98 pages | ID: U6263619730EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cetuximab

Revenue, means the sales value of Cetuximab

This report studies sales (consumption) of Cetuximab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi SA (France)
• Wyeth (US)
• GlaxoSmithKline Plc (UK)
• Abbott Laboratories (USA)
• Pfizer Inc. (USA)
• Eli Lilly and Company (US)
• Merck & Co., Inc. (US)
• Warner Chilcott plc (Ireland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Cetuximab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Cetuximab Market Report 2016

1 CETUXIMAB OVERVIEW

1.1 Product Overview and Scope of Cetuximab
1.2 Classification of Cetuximab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cetuximab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cetuximab (2011-2021)
  1.4.1 United States Cetuximab Sales and Growth Rate (2011-2021)
  1.4.2 United States Cetuximab Revenue and Growth Rate (2011-2021)

2 UNITED STATES CETUXIMAB COMPETITION BY MANUFACTURERS

2.1 United States Cetuximab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cetuximab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cetuximab Average Price by Manufactures (2015 and 2016)
2.4 Cetuximab Market Competitive Situation and Trends
  2.4.1 Cetuximab Market Concentration Rate
  2.4.2 Cetuximab Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CETUXIMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cetuximab Sales and Market Share by Type (2011-2016)
3.2 United States Cetuximab Revenue and Market Share by Type (2011-2016)
3.3 United States Cetuximab Price by Type (2011-2016)
3.4 United States Cetuximab Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CETUXIMAB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cetuximab Sales and Market Share by Application (2011-2016)
4.2 United States Cetuximab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CETUXIMAB MANUFACTURERS PROFILES/ANALYSIS

5.1 Sanofi SA (France)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cetuximab Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Sanofi SA (France) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Wyeth (US)
  5.2.2 Cetuximab Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Wyeth (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Cetuximab Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Abbott Laboratories (USA)
  5.4.2 Cetuximab Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Abbott Laboratories (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer Inc. (USA)
  5.5.2 Cetuximab Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Inc. (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Eli Lilly and Company (US)
  5.6.2 Cetuximab Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Eli Lilly and Company (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Merck & Co., Inc. (US)
  5.7.2 Cetuximab Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Merck & Co., Inc. (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Warner Chilcott plc (Ireland)
  5.8.2 Cetuximab Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Warner Chilcott plc (Ireland) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 CETUXIMAB MANUFACTURING COST ANALYSIS

6.1 Cetuximab Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cetuximab

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cetuximab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cetuximab Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CETUXIMAB MARKET FORECAST (2016-2021)

10.1 United States Cetuximab Sales, Revenue Forecast (2016-2021)
10.2 United States Cetuximab Sales Forecast by Type (2016-2021)
10.3 United States Cetuximab Sales Forecast by Application (2016-2021)
10.4 Cetuximab Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cetuximab
Table Classification of Cetuximab
Figure United States Sales Market Share of Cetuximab by Type in 2015
Table Application of Cetuximab
Figure United States Sales Market Share of Cetuximab by Application in 2015
Figure United States Cetuximab Sales and Growth Rate (2011-2021)
Figure United States Cetuximab Revenue and Growth Rate (2011-2021)
Table United States Cetuximab Sales of Key Manufacturers (2015 and 2016)
Table United States Cetuximab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cetuximab Sales Share by Manufacturers
Figure 2016 Cetuximab Sales Share by Manufacturers
Table United States Cetuximab Revenue by Manufacturers (2015 and 2016)
Table United States Cetuximab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cetuximab Revenue Share by Manufacturers
Table 2016 United States Cetuximab Revenue Share by Manufacturers
Table United States Market Cetuximab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cetuximab Average Price of Key Manufacturers in 2015
Figure Cetuximab Market Share of Top 3 Manufacturers
Figure Cetuximab Market Share of Top 5 Manufacturers
Table United States Cetuximab Sales by Type (2011-2016)
Table United States Cetuximab Sales Share by Type (2011-2016)
Figure United States Cetuximab Sales Market Share by Type in 2015
Table United States Cetuximab Revenue and Market Share by Type (2011-2016)
Table United States Cetuximab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cetuximab by Type (2011-2016)
Table United States Cetuximab Price by Type (2011-2016)
Figure United States Cetuximab Sales Growth Rate by Type (2011-2016)
Table United States Cetuximab Sales by Application (2011-2016)
Table United States Cetuximab Sales Market Share by Application (2011-2016)
Figure United States Cetuximab Sales Market Share by Application in 2015
Table United States Cetuximab Sales Growth Rate by Application (2011-2016)
Figure United States Cetuximab Sales Growth Rate by Application (2011-2016)
Table Sanofi SA (France) Basic Information List
Table Sanofi SA (France) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Cetuximab Sales Market Share (2011-2016)
Table Wyeth (US) Basic Information List
Table Wyeth (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wyeth (US) Cetuximab Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Cetuximab Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Cetuximab Sales Market Share (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. (USA) Cetuximab Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Cetuximab Sales Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc. (US) Cetuximab Sales Market Share (2011-2016)
Table Warner Chilcott plc (Ireland) Basic Information List
Table Warner Chilcott plc (Ireland) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Warner Chilcott plc (Ireland) Cetuximab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cetuximab
Figure Manufacturing Process Analysis of Cetuximab
Figure Cetuximab Industrial Chain Analysis
Table Raw Materials Sources of Cetuximab Major Manufacturers in 2015
Table Major Buyers of Cetuximab
Table Distributors/Traders List
Figure United States Cetuximab Production and Growth Rate Forecast (2016-2021)
Figure United States Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Table United States Cetuximab Production Forecast by Type (2016-2021)
Table United States Cetuximab Consumption Forecast by Application (2016-2021)